Relmada Therapeutics
Develops NDV-01 for NMIBC and sepranolone for Prader-Willi syndrome.
$4.33
After-hours close−0.00 (−0.12%)
At close$4.34(−4.09%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.20 | −$0.11 | +44.9% |
| May 2026 | −$0.18 | −$0.22 | −22.2% |
| Mar 2026 | −$0.14 | −$0.27 | −92.9% |
| Nov 2025 | −$0.04 | −$0.30 | −650.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.14 | — | — | — | — | — |
| Aug 6, 2026 | −$0.20 | −$0.11 | +44.9% | — | — | — |
| May 12, 2026 | −$0.18 | −$0.22 | −22.2% | — | — | — |
| Mar 19, 2026 | −$0.14 | −$0.27 | −92.9% | — | — | — |
| Nov 13, 2025 | −$0.04 | −$0.30 | −650.0% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 27, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 19, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 5, 2022 | ||||||
| Mar 23, 2022 | ||||||
| Nov 11, 2021 | ||||||
| Aug 10, 2021 | ||||||
| May 12, 2021 | ||||||
| Mar 23, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 12, 2020 | ||||||
| May 15, 2020 | ||||||
| Mar 26, 2020 | ||||||
| Nov 13, 2019 | ||||||
| Sep 24, 2019 | ||||||
| May 14, 2019 | ||||||
| Feb 13, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Sep 28, 2018 | ||||||
| May 14, 2018 | ||||||
| Feb 12, 2018 | ||||||
| Nov 14, 2017 | ||||||
| Sep 28, 2017 | ||||||
| May 15, 2017 | ||||||
| Feb 10, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Sep 12, 2016 | ||||||
| May 9, 2016 | ||||||
| Feb 5, 2016 | ||||||
| Nov 6, 2015 | ||||||
| Sep 11, 2015 | ||||||